A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles
Molecules, 2021 Dimethyl fumarate is a cytoprotective and immunomodulatory drug used in the treatment of multiple sclerosis. We performed a bibliometric study examining the characteristics and trends of the top 100 cited articles that include dimethyl fumarate in the ...
Francisco Javier García-Fernández +6 more
doaj +1 more source
Patients monitoring during treatment with Dimethyl fumarate (ORP-23) [PDF]
Neurology Letters, 2023 Dimethyl Fumarate (DMF) is a methyl ester of fumaric acid (chemical formula C6H8O4) that is hydrolyzed in the small intestine to the active metabolite monomethyl fumarate, approved for the treatment of RMS, and moderate to severe Psoriasis.
Ali Yousefi Pour
doaj
Trispyrazolylborate Ligands Supported on Vinyl Addition Polynorbornenes and Their Copper Derivatives as Recyclable Catalysts [PDF]
, 2019 Polynorbornenes prepared by vinyl addition poly- merization and bearing pendant alkenyl groups serve as skeletons to support trispyrazolylborate ligands (Tpx) built at those alkenyl sites.
Albéniz Jiménez, Ana Carmen +6 more
core +2 more sources
Decomposition of Bayer process organics: Phenolates, polyalcohols, and additional carboxylates [PDF]
, 2011 The degradation of nineteen low-molecular-weight phenolates, polyalcohols and selected aliphatic and aromatic carboxylates of relevance to the Bayer process has been studied in 6 mol kg-1 NaOH(aq) at 90 °C for up to 36 days, and (for some species) at 180
Hefter, G.T. +4 more
core +2 more sources
Journal of Investigative Medicine High Impact Case Reports, 2020 Progressive multifocal leukoencephalopathy (PML) is a serious infective disease of the central nervous system that may occur in case of severe immunosuppression or after some treatment for multiple sclerosis (MS) with natalizumab, dimethyl fumarate, and ...
Stefania Federica De Mercanti MD, PhD +5 more
doaj +1 more source
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
Acta Dermato-Venereologica, 2023 is missing (Short communication)
Laura Gnesotto +17 more
doaj +1 more source
Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report
International Journal of Women's Dermatology, 2019 A 69-year-old woman affected by multiple sclerosis for 35 years was diagnosed with bullous pemphigoid (BP) and treated successfully with dimethyl fumarate (DMF) at a dose of 120 mg twice per day for 7 days and then increased to 240 mg twice per day after
Aslı Bilgic-Temel, MD +2 more
doaj +1 more source
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Pharmaceuticals, 2020 Fumaric acid esters (FAEs) are small molecules with anti-oxidative, anti-inflammatory and immune-modulating effects. Dimethyl fumarate (DMF) is the best characterised FAE and is approved and registered for the treatment of psoriasis and Relapsing ...
Stephanie Kourakis +5 more
doaj +1 more source
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus [PDF]
, 2018 Although natalizumab (anti-α4 integrin) represents an effective therapy for relapsing remitting multiple sclerosis (RRMS), it is associated with an increased risk of developing progressive multifocal leukoencephalopathy (PML), caused by the polyomavirus ...
Anzivino, Elena +16 more
core +3 more sources
Clinical & Translational Immunology, 2023 Objectives Multiple sclerosis (MS) is a neurodegenerative disease characterised by inflammation and damage to myelin sheaths. While all current disease‐modifying treatments (DMTs) are very effective at reducing relapses, they do not slow the progression ...
Katharina Robichon +6 more
doaj +1 more source